Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic LeukemiaJohn C. Byrd, Susan O’Brien, Richard R. Furman et al.|New England Journal of Medicine|2013Cited by 2.2k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic LeukemiaJan A. Burger, Thomas J. Kipps, Alessandra Tedeschi et al.|New England Journal of Medicine|2015Cited by 1.6k
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironmentJan A. Burger, Thomas J. Kipps|Blood|2005Cited by 1.2k
Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell–derived factor-1Jan A. Burger, Thomas J. Kipps|Blood|2000Cited by 732
The microenvironment in mature B-cell malignancies: a target for new treatment strategiesJan A. Burger, Federico Caligaris‐Cappio|Blood|2009Cited by 576